Effects of free fatty acid receptor (FFAR) signaling on the modulation of cancer cell functions under hypoxic conditions

Biochem Biophys Res Commun. 2024 Mar 5:699:149554. doi: 10.1016/j.bbrc.2024.149554. Epub 2024 Jan 24.

Abstract

In the tumor environment, hypoxia promotes tumor progression, such as cancer cell growth, migration and chemoresistance. This study aimed to evaluate the roles of free fatty acid receptors (FFARs) in the regulation of cancer cell functions under hypoxic conditions, using fibrosarcoma HT1080 cells. HT1080 cells expressed FFAR1, FFAR2 and FFAR3 genes, but not FFAR4 gene. FFAR1, FFAR2 and FFAR3 expression levels in HT1080 cells cultured at 1 % O2 were elevated, compared with 21 % O2. The cell growth activities of HT1080 cells cultured at 21 % O2 were inhibited by acetic acid (AA) and propanoic acid (PA), but not 1 % O2. HT1080 cell motility was markedly reduced by culturing at 1 % O2. The cell growth and motility of HT1080 cells were enhanced by FFAR2 knockdown. The cell viability to cisplatin (CDDP) of HT1080 cells cultured at 1 % O2 was increased, compared with 21 % O2. FFAR2 knockdown suppressed the cell viability to CDDP of HT1080 cells. On the other hand, the cell motility and viability to CDDP of HT1080 cells cultured at 21 % O2 were suppressed by TUG-770. When HT1080 cells were cultured at 1 % O2, the cell motility and viability to CDDP were decreased, correlating with FFAR1 expression level. Moreover, FFAR1 knockdown increased the cell viability to CDDP of HT1080 cells cultured at 1 % O2. These results suggest that FFAR-mediated signaling plays an important role in the modulation of cellular functions of HT1080 cells under hypoxic conditions.

Keywords: Cell migration; Cell viability; FFA receptor; Fibrosarcoma cells; Hypoxia.

MeSH terms

  • Cell Movement
  • Cisplatin / pharmacology
  • Fatty Acids, Nonesterified*
  • Fibrosarcoma* / metabolism
  • Humans
  • Receptors, G-Protein-Coupled / metabolism
  • Signal Transduction

Substances

  • Fatty Acids, Nonesterified
  • Receptors, G-Protein-Coupled
  • Cisplatin